| [1] |
|
| [2] |
MARTINELLO M, HAJARIZADEH B, GREBELY J, et al. Management of acute HCV infection in the era of direct-acting antiviral therapy[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(7): 412-424. DOI: 10.1038/s41575-018-0026-5. |
| [3] |
LINGALA S, GHANY MG. Natural history of hepatitis C[J]. Gastroenterol Clin North Am, 2015, 44(4): 717-734. DOI: 10.1016/j.gtc.2015.07.003. |
| [4] |
SAGNELLI E, SANTANTONIO T, COPPOLA N, et al. Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment[J]. Infection, 2014, 42(4): 601-610. DOI: 10.1007/s15010-014-0608-2. |
| [5] |
LOOMBA R, RIVERA MM, MCBURNEY R, et al. The natural history of acute hepatitis C: Clinical presentation, laboratory findings and treatment outcomes[J]. Aliment Pharmacol Ther, 2011, 33(5): 559-565. DOI: 10.1111/j.1365-2036.2010.04549.x. |
| [6] |
COX AL, NETSKI DM, MOSBRUGER T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection[J]. Clin Infect Dis, 2005, 40(7): 951-958. DOI: 10.1086/428578. |
| [7] |
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for hepatitis C (2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008. |
| [8] |
GALLI C, JULICHER P, PLEBANI M. HCV core antigen comes of age: A new opportunity for the diagnosis of hepatitis C virus infection[J]. Clin Chem Lab Med, 2018, 56(6): 880-888. DOI: 10.1515/cclm-2017-0754. |
| [9] |
ZHANG YQ, WANG J, CHANG JX, et al. Correlation and the clinical significance of hepatitis C virus RNA and hepatitis C core antigen[J/CD]. Chin J Exp Clin Infect Dis: Electronic Edition, 2019, 13(3): 185-189. DOI: 10.3877//cma.j.issn.1674-1358.2019.03.003. |
| [10] |
CHEVALIEZ S, FELD J, CHENG K, et al. Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen[J]. Antivir Ther, 2018, 23(3): 211-217. DOI: 10.3851/IMP3042. |
| [11] |
GHANY MG, MORGAN TR, AASLD-IDSA Hepatitis C guidance panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection[J]. Hepatology, 2020, 71(2): 686-721. DOI: 10.1002/hep.31060. |
DownLoad: